DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Herceptin (Trastuzumab) - Current Clinical Trials

 
 



Herceptin Related Clinical Trials

Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer [Active, not recruiting]

Faslodex and Herceptin, Alone and Combined [Recruiting]

A Study to Compare Subcutaneous Versus Intravenous Administration of Herceptin (Trastuzumab) in Women With HER2Positive Early Breast Cancer [Recruiting]

Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer [Completed]

Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients [Completed]

Preoperative Herceptin and Navelbine for Breast Cancer [Active, not recruiting]

Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer [Active, not recruiting]

Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer [Recruiting]

Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen [Recruiting]

MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer [Recruiting]

Neoadjuvant Herceptin in Patients With Breast Cancer [Active, not recruiting]

A Study of Herceptin (Trastuzumab)and Biomarkers in Patients With HER2-Positive Metastatic Breast Cancer [Recruiting]

Trastuzumab With or Without Everolimus in Estrogen Receptor-Positive Metastatic Breast Cancer [Recruiting]

Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab [Not yet recruiting]

A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer [Not yet recruiting]

Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer [Recruiting]

A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer [Recruiting]

A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to Trastuzumab [Not yet recruiting]

A Study of Herceptin (Trastuzumab) in Combination With 2nd-Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer. [Recruiting]

Combination Study of BMS-754807 and Herceptin« in Patients With Advanced or Metastatic Her-2-positive Breast Cancer [Recruiting]

A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2-Positive Metastatic Breast Cancer Patients [Recruiting]

GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer [Recruiting]

Delayed Adjuvant Herceptin« Treatment in Patients With HER-2 Positive Breast Cancer [Terminated]

Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer [Recruiting]

Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC) [Recruiting]

Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors [Recruiting]

Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2 [Recruiting]

GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases [Recruiting]

Trastuzumab Optimization Trial in Breast Cancer [Recruiting]

A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer [Recruiting]

Experience of the Patient Treated With Trastuzumab (Herceptin «) as Adjuvant for Breast Cancer [Recruiting]

Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax [Not yet recruiting]

Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer [Recruiting]

Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer [Recruiting]

Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer [Recruiting]

Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients [Recruiting]

A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol. [Recruiting]

A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Patients With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment [Recruiting]

GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast Cancer [Active, not recruiting]

Safety Study of ┬▓┬╣┬▓Pb-TCMC-Trastuzumab Radio Immunotherapy [Recruiting]

Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis [Recruiting]

A Study to Evaluate the Efficacy and Safety of Herceptin (Trastuzumab) in Combination With an Aromatase Inhibitor in Patients With Metastatic Breast Cancer [Active, not recruiting]

A Phase II Neo-adjuvant Study Assessing TCH (Docetaxel, Carboplatin and Trastuzumab), TCL (Docetaxel, Carboplatin and Lapatinib) and the Combination of TCHL (Docetaxel,Carboplatin, Trastuzumab and Lapatinib) in HER-2 Positive Breast Cancer Patients. [Recruiting]

Phase I Trial of Afatinib and Trastuzumab [Recruiting]

Trastuzumab Plus Interleukin-2 in Treating Patients With Metastatic Breast Cancer [Active, not recruiting]

PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer

Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer [Completed]

Letrozole and Herceptin in Her2neu Positive, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, Metastatic Breast Cancer [Active, not recruiting]

Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With Trastuzumab [Suspended]

Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer [Active, not recruiting]

Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer [Terminated]

Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer [Terminated]

Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas

A Phase 1/2 Study Of HKI-272 In Combination With Herceptin In Subjects With Advanced Breast Cancer [Recruiting]

Study of Larotaxel in Combination With Weekly Herceptin« in Patients With HER2 Positive Metastatic Breast Cancer [Recruiting]

TBP Study With Capecitabine Plus Minus Trastuzumab

Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer [Withdrawn]

Celecoxib and Trastuzumab in Treating Women With Metastatic Breast Cancer [Completed]

Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer

A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer [Recruiting]

GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu [No longer recruiting]

Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast Cancer [Recruiting]

Trastuzumab and Capecitabine in Treating Women With Metastatic Breast Cancer [No longer recruiting]

Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer [Recruiting]

Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab [Active, not recruiting]

Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity [Recruiting]

Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer [Recruiting]

Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer [Recruiting]

Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast [Recruiting]

Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients [Recruiting]

Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients [Recruiting]

Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer [No longer recruiting]

A Dose Finding Study of Subcutaneous Herceptin (Trastuzumab) in Healthy Male Volunteers and HER2 Positive Female Patients [Recruiting]

Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma [No longer recruiting]

Herceptin and GM-CSF for Metastatic Breast Cancer [Recruiting]

Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer [Recruiting]

Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer [No longer recruiting]

Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer [No longer recruiting]

Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer [Recruiting]

Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer

A Study of the Efficacy and Safety of Trastuzumab-MCC-DM1 vs. Trastuzumab (Herceptin«) and Docetaxel (Taxotere«) in Patients With Metastatic HER2-Positive Breast Cancer Who Have Not Received Prior Chemotherapy for Metastatic Disease [Recruiting]

Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer [Recruiting]

Effects of Granulocyte Colony-Stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function [Recruiting]

CPG 7909 Plus Herceptin« in Patients With Metastatic Breast Cancer [Completed]

ErbB2 Over-Expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib [Recruiting]

Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [No longer recruiting]

Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-Positive Breast Cancer (Study P05048AM2) [Recruiting]

Safety and Efficacy Study of the Combination of CpG 7909 and Herceptin in Patients With Metastatic Breast Cancer [Completed]

THOR Study: A Study of Continued Herceptin (Trastuzumab) in Combination With Second Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer. [Recruiting]

PET Imaging With Cu-64 Labeled Trastuzumab in HER2+ Metastatic Breast Cancer [Recruiting]

Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer [Recruiting]

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer [Completed]

Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients [Recruiting]

Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive [Recruiting]

Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer [Recruiting]

Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast Cancer [Recruiting]

Oral Deforolimus With Trastuzumab for Patients With HER2-Positive Trastuzumab-Refractory Metastatic Breast Cancer [Recruiting]

Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin«) in Advanced Breast Carcinoma [Recruiting]

Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF) [Recruiting]

A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer. [Recruiting]

Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer [No longer recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014